|
|
||||||||
J Thorac Cardiovasc Surg 1999;117:843-844
© 1999 Mosby, Inc.
LETTERS TO THE EDITOR |
Clinical Professor EmeritusDepartment of Congenital Heart Disease and Pediatric Cardiologya
Department of Thoracic and Cardiovascular Surgeryb
Deutsches Herzzentrum Berlin
Berlin, Germany
Serum S-100 protein levels after pediatric cardiac surgery: A possible new marker for postperfusion cerebral injury
To the Editors:
We read with great interest the publication of Lindberg and associates
1 in this Journal on the serum S-100 protein levels after pediatric cardiac surgery.
In our institution we have used this marker as a routine biochemical monitoring parameter before and after corrective cardiac operations in infants. We have published several studies concerning the release patterns of S-100 in association with other neurologic monitoring methods, such as near-infrared spectroscopy and transcranial Doppler sonography.
We have also found a close relationship between the age and weight at operation and the measured peak values before and after cardiopulmonary bypass (CPB).
2 Our postoperative release patterns in infants and children are similar to those results of Lindberg and colleagues. The postoperative peak values correlated to age (r = 0.77, P < .0001) and weight (r = 0.71, P < .0001) of the studied infants.
2
In the study of Lindberg and associates, however, we miss the presence of a control group to show that the protein S-100 levels are not similarly increased after operations without CPB. As appropriate controls, we use infants undergoing corrective surgery for coarctation of the aorta without CPB.
It remains unclear whether these transient elevations of postbypass S-100 values indicate "normal patterns," inasmuch as infants with evident clinical brain injury had much higher levels, more than 2 SD of those without cerebral and neurologic complications (Fig 1). Possible subclinical brain injury associated with transient elevation of the serum levels of protein S-100, therefore, have to be evaluated with the use of additional neurophysiologic methods and neurodevelopmental follow-up studies. Higher serum concentrations than the peak S-100 values in all infants were found in 5 infants with neurologic and cardiac complications (Fig 1
).
|
We also agree with Lindberg and his coauthors' speculation that the possible lack of maturation of the blood-brain barrier may be a factor causing the higher release of protein S-100 in neonates than in infants.
2 However, in addition to the inflammatory processes, oxygen-derived free radicals induce endothelial reperfusion injury and may contribute to the alteration of the blood-brain barrier.
5 Thus measurement of malondialdehyde, a fragment of lipid peroxidation, in the serum may provide possible information on accentuated structural membrane injury
5 by free radicals.
5,6
Significant increases of malondialdehyde values, as well as a concomitant significant increase of the serum concentration of the astroglial protein S-100, were found between crossclamping and unclamping of the aorta.
6
In conclusion, we found similar age-dependent release patterns of the protein S-100 in neonates and infants in comparison with infants undergoing surgery without CPB. A pathologic mechanism underlying the release of protein S-100 in the serum might be an induced reperfusion injury and possible transient functional and/or structural alteration of the brain-blood barrier.
12/8/95918
References
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |